At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
GRI GRI BIO INC
Trading 10-15 11:18:11 EDT
1.38
-0.02
-1.43%
High1.44
Low1.38
Vol16.58K
Open1.43
D1 Closing1.40
Amplitude3.93%
Mkt Cap3.02M
Tradable Cap3.01M
Total Shares2.19M
T/O23.15K
T/O Rate0.76%
Tradable Shares2.18M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Press Release: Veteran Commercial Real Estate Banker Cesar "Ces" Escamilla Joins EagleBank to Accelerate Growth
GRI Bio, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that develops as an oral therapeutic for liver disease. GRI Bio, Inc. was formerly know as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in La Jolla, California.